Oracle Hopes to Strike Bioinformatics Gold with Embedded Data-Mining Tools | GenomeWeb

Oracle currently claims to hold 85 percent of the life science research database market, but the company isn’t resting on its laurels. On the contrary, the database giant is expanding the capabilities of its software in a bid to retain its edge in the increasingly competitive market. For the bioinformatics sector, the company is offering a suite of data-mining tools that are embedded within its database and that can provide a level of functionality many Oracle customers may not even know they already have.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.